KCNK1 inhibits osteoclastogenesis by blocking the Ca2+ oscillation and JNK-NFATc1 signaling axis

Jeong-Tae Yeon1, Kwang-Jin Kim2, Sang Woo Chun3

  • 1Research Institute of Basic Science, Sunchon National University, Suncheon 540-742, Republic of Korea.

Insights

KCNK1, a potassium channel, negatively regulates osteoclast differentiation. Its inhibition may offer therapeutic strategies for bone disorders by modulating calcium signaling and JNK-NFATc1 pathways.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Physiology

Background:

  • KCNK1 (K(+) channel, subfamily K, member 1) influences membrane potential.
  • Osteoclast differentiation is crucial for bone remodeling and is implicated in bone diseases.

Purpose of the Study:

  • To investigate the role of KCNK1 in osteoclast differentiation.
  • To elucidate the underlying molecular mechanisms of KCNK1's function in osteoclasts.

Main Methods:

  • Studied KCNK1 expression during osteoclast differentiation.
  • Utilized functional overexpression and knockdown of KCNK1.
  • Assessed RANKL-induced signaling pathways, including Ca(2+) oscillation, JNK activation, and NFATc1 expression.

Main Results:

  • KCNK1 expression increased during osteoclast differentiation.
  • KCNK1 overexpression inhibited RANKL-induced osteoclast differentiation, Ca(2+) oscillation, JNK activation, and NFATc1 expression.
  • KCNK1 knockdown enhanced RANKL-induced osteoclast differentiation and associated signaling.

Conclusions:

  • KCNK1 acts as a negative regulator of osteoclast differentiation.
  • Modulating KCNK1 activity may impact Ca(2+) influx and the JNK-NFATc1 pathway.
  • Understanding KCNK1's role could inform therapies for osteoclast-related disorders.

Related Concept Videos

Osteoclasts in Bone Remodeling01:31

Osteoclasts in Bone Remodeling

Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...
4.8K
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
10.4K
NF-kB-dependent Signaling Pathway02:26

NF-kB-dependent Signaling Pathway

2.5K
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
9.3K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
6.2K
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

5.7K